| Basics |
Charles River Laboratories International, Inc.
Charles River Laboratories International Inc is a pharmaceutical company providing drug discovery and development services. The company provides animal models for laboratory testing, and offers manufacturing testing services to various industries.
|
| IPO Date: |
June 23, 2000 |
| Sector: |
Healthcare |
| Industry: |
Life Sciences Tools and Services |
| Market Cap: |
$9.07B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.37 | 1.20%
|
| Avg Daily Range (30 D): |
$2.21 | 1.26%
|
| Avg Daily Range (90 D): |
$2.55 | 1.54%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.53M |
| Avg Daily Volume (30 D): |
.82M |
| Avg Daily Volume (90 D): |
.74M |
| Trade Size |
| Avg Trade Size (Sh.): |
88 |
| Avg Trade Size (Sh.) (30 D): |
40 |
| Avg Trade Size (Sh.) (90 D): |
37 |
| Institutional Trades |
| Total Inst.Trades: |
13,329 |
| Avg Inst. Trade: |
$4.21M |
| Avg Inst. Trade (30 D): |
$14.32M |
| Avg Inst. Trade (90 D): |
$15.58M |
| Avg Inst. Trade Volume: |
.04M |
| Avg Inst. Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$8.54M |
| Avg Closing Trade (30 D): |
$29.52M |
| Avg Closing Trade (90 D): |
$26.32M |
| Avg Closing Volume: |
55.33K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$-1.52
|
$1.11
|
$1.06
|
|
Diluted EPS
|
$-1.52
|
$1.1
|
$1.06
|
|
Revenue
|
$ 4.02B
|
$ 1B
|
$ 1.03B
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -79.62M
|
$ 55.56M
|
$ 52.69M
|
|
Operating Income / Loss
|
$ 140.92M
|
$ 133.8M
|
$ 100.13M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ -2.42M
|
$ 24.48M
|
$ -46.99M
|
|
PE Ratio
|
|
|
|
|
|
|
